Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017:2017:6854913.
doi: 10.1155/2017/6854913. Epub 2017 Oct 17.

Mycoplasma Pneumonia: An Unrecognized Cause of Fever of Unknown Origin in an Adult

Affiliations
Case Reports

Mycoplasma Pneumonia: An Unrecognized Cause of Fever of Unknown Origin in an Adult

Fatima Ali-Ahmed et al. Case Rep Infect Dis. 2017.

Abstract

A 26-year-old female was admitted for fever of unknown origin (FUO), headaches, left ankle edema, and a lower extremity rash consistent with erythema nodosum. She had no respiratory symptoms or family history of autoimmune diseases. A chest X-ray was negative for pneumonia or hilar adenopathy. Extensive autoimmune workup was negative. A chest, abdomen, and pelvis computed tomography scan was unremarkable and laboratory studies revealed no source of infection. On hospital day 5, the patient developed a mild productive cough. Her Mycoplasma pneumonia (MP) IgM was high, confirming the diagnosis of MP induced FUO. She was started on azithromycin 500 mg daily and within 24 hours her fevers and headaches resolved. Her left ankle edema and EN gradually improved over a course of a few weeks. This case report highlights the need for MP testing in the evaluation of fever of unknown origin, even in the absence of pulmonary manifestations.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Erythema nodosum on pretibial surface of lower extremity.

Similar articles

Cited by

References

    1. Waites K. B., Talkington D. F. Mycoplasma pneumoniae and its role as a human pathogen. Clinical Microbiology Reviews. 2004;17(4):697–728. doi: 10.1128/CMR.17.4.697-728.2004. - DOI - PMC - PubMed
    1. Kashyap S., Sarkar M. Mycoplasma pneumonia: clinical features and management. Lung India. 2010;27(2):75–85. doi: 10.4103/0970-2113.63611. - DOI - PMC - PubMed
    1. Beersma M. F. C., Dirven K., Van Dam A. P., Templeton K. E., Claas E. C. J., Goossens H. Evaluation of 12 commercial tests and the complement fixation test for Mycoplasma pneumoniae-specific immunoglobulin G (IgG) and IgM antibodies, with PCR used as the "gold standard". Journal of Clinical Microbiology. 2005;43(5):2277–2285. doi: 10.1128/JCM.43.5.2277-2285.2005. - DOI - PMC - PubMed
    1. Talkington D. F., Shott S., Fallon M. T., Schwartz S. B., Thacker W. L. Analysis of eight commercial enzyme immunoassay tests for detection of antibodies to Mycoplasma pneumoniae in human serum. Clinical and Diagnostic Laboratory Immunology. 2004;11(5):862–867. doi: 10.1128/CDLI.11.5.862-867.2004. - DOI - PMC - PubMed
    1. Sánchez-Vargas F. M., Gómez-Duarte O. G. Mycoplasma pneumoniae—an emerging extra-pulmonary pathogen. Clinical Microbiology and Infection. 2008;14(2):105–115. doi: 10.1111/j.1469-0691.2007.01834.x. - DOI - PubMed

Publication types

LinkOut - more resources